We are live on ! Find out more
IMUX icon

Immunic
IMUX

69 hedge funds and large institutions have $149M invested in Immunic in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

699% more call options, than puts

Call options by funds: $2.58M | Put options by funds: $323K

100% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 14

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

5% more funds holding

Funds holding: 66 → 69 (+3)

0.57% more ownership

Funds ownership: 4.12% → 4.7% (+0.57%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less capital invested

Capital invested by funds: $153M → $149M (-$3.83M)

Holders
69
Holders Change
+3
Holders Change %
+4.55%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
28
Reduced
14
Closed
9
Calls
$2.58M
Puts
$323K
Net Calls
+$2.26M
Net Calls Change
+$661K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$7.44M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.82M
3
BlackRock
BlackRock
New York
+$3.91M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.67M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.48M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$4.67M
2
IBT
International Biotechnology Trust
United Kingdom
-$2.28M
3
Millennium Management
Millennium Management
New York
-$2.15M
4
AG
Artal Group
Luxembourg
-$1.8M
5
SSA
Schonfeld Strategic Advisors
New York
-$930K
Name Holding Trade Value Shares
Change 		Change in
Stake
OFM
1
Omega Fund Management
Massachusetts
$27.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$20.2M +$5.82M +32,407 +33%
RI
3
RTW Investments
New York
$14.1M +$149K +831 +0.9%
BlackRock
4
BlackRock
New York
$11M +$3.91M +21,790 +43%
AG
5
Artal Group
Luxembourg
$10.7M -$1.8M -10,000 -13%
Vanguard Group
6
Vanguard Group
Pennsylvania
$10.4M +$595K +3,315 +5%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$6.34M +$7.44M +41,448 New
PHP
8
Parkman Healthcare Partners
Connecticut
$5.61M -$599K -3,333 -8%
GTC
9
Ghost Tree Capital
New York
$4.05M – – –
ACM
10
Altium Capital Management
New York
$3.73M +$4.38M +24,416 New
Millennium Management
11
Millennium Management
New York
$3.26M -$2.15M -11,969 -36%
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$3.13M +$3.67M +20,450 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$3.08M +$1.48M +8,240 +69%
Two Sigma Investments
14
Two Sigma Investments
New York
$3.05M +$254K +1,415 +8%
N
15
Nuveen
North Carolina
$2.4M -$146K -814 -5%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.33M +$415K +2,313 +18%
ECM
17
Endurant Capital Management
California
$2.12M +$497K +2,770 +25%
Northern Trust
18
Northern Trust
Illinois
$1.79M -$91.2K -508 -4%
Ensign Peak Advisors
19
Ensign Peak Advisors
Utah
$1.41M – – –
State Street
20
State Street
Massachusetts
$1.32M +$281K +1,567 +22%
Verition Fund Management
21
Verition Fund Management
Connecticut
$1.22M +$629K +3,502 +78%
GG
22
Golden Green
South Carolina
$1.08M +$1.27M +7,090 New
Squarepoint
23
Squarepoint
New York
$637K +$313K +1,745 +72%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$619K +$92.5K +515 +15%
SSA
25
Schonfeld Strategic Advisors
New York
$605K -$930K -5,180 -57%
1
2 3 4

IMUX Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2020, worth a combined $149M — down 2.5% from $153M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IMUX positions and 9 closed out — a net gain of 4 holders — while 28 added to existing stakes and 14 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $7.44M. The largest seller was Invesco, exiting entirely with an estimated $4.67M sold.

  • 69 institutional investors held Immunic (IMUX) as of Q4 2020, up from 66 in Q3 2020.
  • Funds reported $149M of Immunic stock for Q4 2020, down 2.5% quarter-over-quarter.
  • 13 funds opened new Immunic positions in Q4 2020 and 9 closed out, a net change of +4 holders.
  • The largest Immunic buyer in Q4 2020 was T. Rowe Price Associates, an estimated $7.44M added.
  • The largest Immunic seller in Q4 2020 was Invesco, an estimated $4.67M sold.

Based on aggregated 13F filings for Q4 2020.